Genetic basis of physical fitness

Annual Review of Anthropology

Volumn 36, Issue , 2007, Pages 391-405

  Montgomery, Hugh ^a   Safari, Latif ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Exercise; Genotype; Performance; Phenotype; Polymorphism; Selection

Indexed keywords

DNA; GENOTYPE; PHENOTYPE; PHYSIOLOGY; POLYMORPHISM;

EID: 35948979335     PISSN: 00846570     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.anthro.36.081406.094333     Document Type: Article

References (111)

1. Alvarez R, Terrados N, Ortolano R, Iglesias-Cubero G, Reguero JR, et al. 2000. Genetic variation in the renin-angiotensin system and athletic performance. Eur. J. Appl. Physiol. 82:117-20
2. Beunen G, Thomis M. 1999. Genetic determinants of sports participation and daily physical activity. Int. J. Obes. Relat. Metab. Disord. 23(Suppl. 3):S55-63
3. Beunen G, Thomis M. 2004. Gene powered? Where to go from heritability (h2) in muscle strength and power? Exerc. Sport Sci. Rev. 32:148-54
4. Bloem LJ, Manatunga AK, Pratt JH. 1996. Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 27:62-66
5. 2max in the sedentary state: the HERITAGE family study. Med. Sci. Sports Exerc. 30:252-58
6. Bouchard C, Malina RM. 1983. Genetics of physiological fitness and motor performance. Exerc. Sport Sci. Rev. 11:306-39
7. Bouchard C, Rankinen T, Chagnon YC, Rice T, Perusse L, et al. 2000. Genomic scan for maximal oxygen uptake and its response to training in the HERITAGE Family Study. J. Appl. Physiol. 88:551-59
8. Braun A, Kammerer S, Maier E, Bohme E, Roscher AA. 1996. Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology 33:32-35
9. Brink M, Price SR, Chrast J, Bailey JL, Anwar A, et al. 2001. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 142:1489-96
10. Brull D, Dhamrait S, Myerson S, Erdmann J, Woods D, et al. 2001. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet 358:1155-56
11. Cam FS, Colakoglu M, Sekuri C, Colakoglu S, Sahan C, Berdeli A. 2005. Association between the ACE I/D gene polymorphism and physical performance in a homogeneous nonelite cohort. Can. J. Appl. Physiol. 30:74-86
12. Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, et al. 2005. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J. Appl. Physiol. 99:154-63
13. Collins M, Xenophontos SL, Cariolou MA, Mokone GG, Hudson DE, et al. 2004. The ACE gene and endurance performance during the South African Ironman Triathlons. Med. Sci. Sports Exerc. 36:1314-20
14. Costa EM, Blau HM, Feldman D. 1986. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 119:2214-20
15. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. 1993. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290(Pt 1):33-40
16. Da Cruz IB, Oliveira G, Taufer M, Leal NF, Schwanke CH, et al. 2003. Angiotensin I-converting enzyme gene polymorphism in two ethnic groups living in Brazil's southern region: association with age. J. Gerontol. A Biol. Sci. Med. Sci. 58:M851-56
17. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, et al. 1995. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387-88
18. Dayi SU, Tartan Z, Terzi S, Kasikcioglu H, Uyarel H, et al. 2005. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery. Heart Surg. Forum 8:E373-77
19. Dhamrait SS, James L, Brull DJ, Myerson S, Hawe E, et al. 2003. Cortical bone resorption during exercise is interleukin-6 genotype-dependent. Eur. J. Appl. Physiol. 89:21-25
20. 2max, and response to endurance training. Med. Sci. Sports Exerc. 25:766-74
21. Dzau VJ. 1988. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77:I4-13
22. Engeli S, Schling P, Gorzelniak Y, Boschmann M, Janke J, et al. 2003. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int. J. Biochem. Cell Biol. 35:807-25
23. Fatini C, Guazzelli P, Manetti P, Battaglini B, Gensini F, et al. 2000. RAS genes influence exercise-induced left ventricular hypertrophy: an elite athletes study. Med. Sci. Sports Exerc. 32:1868-72
24. Ferrari SL, Rizzoli R. 2005. Gene variants for osteoporosis and their pleiotropic effects in aging. Mol. Aspects Med. 26:145-67
25. Folland J, Leach B, Little T, Hawker Y, Myerson S, et al. 2000. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp. Physiol. 85:575-79
26. Frederiksen H, Gaist D, Bathum L, Andersen Y, McGue M, et al. 2003. Angiotensin I-converting enzyme (ACE) gene polymorphism in relation to physical performance, cognition and survival - a follow-up study of elderly Danish twins. Ann. Epidemiol. 13:57-65
27. Fruchart JC, Duriez P, Staels B. 1999. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr. Opin. Lipidol. 10:245-57
28. Gayagay G, Yu B, Hambly B, Boston T, Hahn A, et al. 1998. Elite endurance athletes and the ACE I allele-the role of genes in athletic performance. Hum. Genet. 103:48-50
29. Geusens P, Vandevyver C, Vanhoof J, Cassiman JJ, Boonen S, Raus J. 1997. Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women. J Bone Miner Res. 12:2082-88
30. Gonzalez-Zuloeta Ladd AM, Vasquez AA, Sayed-Tabatabaei FA, Coebergh JW, Holman A, et al. 2005. Angiotensin-converting enzyme gene insertion/ deletion polymorphism and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 14:2143-46
31. Gordon SE, Davis BS, Carlson CJ, Booth FW. 2001. ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am. J. Physiol. Endocrinol. Metab. 280:E150-59
32. Grundberg E, Brandstrom H, Ribom EL, Ljunggren O, Mallmin H, Kindmark A. 2004. Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur. J. Endocrinol. 150:323-28
33. Grzeszczak W, Misztalski T. 2002. Is insertion/deletion polymorphism angiotensin-converting enzyme gene responsible for long-life? Przegl. Lek. 59:79-83
34. 2max is associated with ACE genotype in postmenopausal women. J. Appl. Physiol. 85:1842-46
35. Hagberg JM, McCole SD, Brown MD, Ferrell RE, Wilund KR, et al. 2002. ACE insertion/ deletion polymorphism and submaximal exercise hemodynamics in postmenopausal women. J. Appl. Physiol. 92:1083-88
36. Harding D, Baines PB, Brull D, Vassiliou V, Ellis I, et al. 2002. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am. J. Respir. Crit. Care Med. 165:1103-6
37. Harding D, Dhamrait S, Marlow N, Whitelaw A, Gupta S, et al. 2003a. Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. J. Pediatr. 143:746-49
38. Harding D, Dhamrait S, Millar A, Humphries S, Marlow N, et al. 2003b. Is interleukin-6-174 genotype associated with the development of septicemia in preterm infants? Pediatrics 112:800-3
39. Harding DR, Dhamrait S, Whitelaw A, Humphries SE, Marlow N, Montgomery BE. 2004. Does interleukin-6 genotype influence cerebral injury or developmental progress after preterm. birth? Pediatrics 114:941-47
40. Heled Y, Moran DS, Mendel L, Laor A, Pras E, Shapiro Y. 2004. Human ACE I/D polymorphism is associated with individual differences in exercise heat tolerance. J. Appl. Physiol. 97:72-76
41. Hernandez D, de la Rosa A, Barragan A, Barrios Y, Salido E, et al. 2003. The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes. J. Am. Coll. Cardiol. 42:527-32
42. Hopkinson NS, Nickol AH, Payne J, Hawe E, Man WD, et al. 2004. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170:395-99
43. Houle S, Landry M, Audet R, Bouthillier J, Bachvarov DR, Marceau F. 2000. Effect of allelic polymorphism of the B(1) and B(2) receptor genes on the contractile responses of the human umbilical vein to kinins. J. Pharmacol. Exp. Ther. 294:45-51
44. Huang QY, Shen H, Deng HY, Conway T, Davies KM, et al. 2003. Linkage and association of the CA repeat polymorphism of the IL6 gene, obesity-related phenotypes, and bone mineral density (BMD) in two independent Caucasian populations. J. Hum. Genet. 48:430-37
45. Jamshidi Y, Montgomery BE, Hense HW, Myerson SG, Torra IP, et al. 2002. Peroxisome proliferator - activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation 105:950-55
46. Jones A, Woods DR. 2003. Skeletal muscle RAS and exercise performance. Int. J. Biochem. Cell Biol. 35:855-66
47. Kasikcioglu E, Kayserilioglu A, Ciloglu F, Akhan H, Oflaz H, et al. 2004. Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes. Heart Vessels 19:287-93
48. Kritchevsky SB, Nicklas BJ, Visser M, Simonsick EM, Newman AB, et al. 2005. Angiotensin-converting enzyme insertion/deletion genotype, exercise, and physical decline. JAMA 294:691-98
49. Lauderdale DS, Fabsitz R, Meyer JM, Sholinsky P, Ramakrishnan V, Goldberg J. 1997. Familial determinants of moderate and intense physical activity: a twin study. Med. Sci. Sports Exerc. 29:1062-68
50. Lee JM, Lo AC, Yang SY, Tsau HS, Chen RJ, Lee YC. 2005. Association of angiotensin-converting enzyme insertion/deletion polymorphism with serum level and development of pulmonary complications following esophagectomy. Ann. Surg. 241:659-65
51. Lievre M, Gueret P, Gayet C, Roudaut R, Haugh MC, et al. 1995. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. HYCAR Study Group. Hypertension 25:92-97
52. Linz W, Scholkens BA. 1992. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J. Pharmacol. 105:771-72
53. Linz W, Wierner G, Schmidts HL, Ulmer W, Ruppert D, Scholkens BA. 1996. ACE inhibition decreases postoperative mortality in rats with left ventricular hypertrophy and myocardial infarction. Clin. Exp. Hypert. 18:691-712
54. Liu Y, Leri A, Li B, Wang Y, Cheng W, et al. 1998. Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes. Circ. Res. 82:1145-59
55. Lucia A, Gomez-Gallego F, Chicharro JL, Hoyos J, Celaya K, et al. 2005. Is there an association between ACE and CKMM polymorphisms and cycling performance status during 3-week races? Int. J. Sports Med. 26:442-47
56. Macarthur DG, North KN. 2005. Genes and human elite athletic performance. Hum. Genet. 116:331-39
57. Maes HH, Beunen GP, Vlietinck RF, Neale MC, Thomis M, et al. 1996. Inheritance of physical fitness in 10-yr-old twins and their parents. Med. Sci. Sports Exerc. 28:1479-91
58. Maia JA, Thomis M, Beunen G. 2002. Genetic factors in physical activity levels: a twin study. Am. J. Prev. Med. 23:87-91
59. Marshall RP, Webb S, Bellingan GJ, Montgomery BE, Chaudhari B, et al. 2002. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 166:646-50
60. McCole SD, Shuldiner AR, Brown MD, Moore GE, Ferrell RE, et al. 2004. Beta2- and beta3-adrenergic receptor polymorphisms and exercise hemodynamics in postmenopausal women. J. Appl. Physiol. 96:526-30
61. Montgomery H, Clarkson P, Barnard M, Bell J, Brynes A, et al. 1999. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 353:541-45
62. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA, et al. 1997. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741-47
63. Montgomery HE, Marshall P, Hemingway H, Myerson S, Clarkson P, et al. 1998. Human gene for physical performance. Nature 393:221-22
64. Morimoto S, Okaishi K, Onishi M, Katsuya T, Yang J, et al. 2002. Deletion allele of the angiotensin-converting enzyme gene as a risk factor for pneumonia in elderly patients. Am. J. Med. 112:89-94
65. Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H. 1999. Human angiotensin I-converting enzyme gene and endurance performance. J. Appl. Physiol. 87:1313-16
66. Myerson SG, Montgomery HE, Whittingham M, Jubb M, World W, et al. 2001. Left ventricular hypertrophy with exercise and ACE gene insertion/ deletion polymorphism: a randomized controlled trial with losartan. Circulation 103:226-30
67. Nazarov IB, Woods DR, Montgomery BE, Shneider OV, Kazakov VI, et al. 2001. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J. Hum. Genet. 9:797-801
68. Panza F, Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, et al. 2003. Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe. Exp. Gerontol. 38:1015-20
69. Patel S, Woods DR, Macleod NJ, Brown A, Patel KR, et al. 2003. Angiotensin-converting enzyme genotype and the ventilatory response to exertional hypoxia. Eur Respir. J. 22:755-60
70. Peeters RP, van den Beld AW, van Toor H, Uitterlinden AG, Janssen JA, et al. 2005. A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J. Clin. Endocrinol. Metab. 90:256-63
71. Pola E, Gaetani E, Pola R, Papaleo P, Flex A, et al. 2002. Angiotensin-converting enzyme gene polymorphism may influence blood loss in a geriatric population undergoing total hip arthroplasty. J. Am. Geriatr Soc. 50:2025-28
72. Rankinen T, Perusse L, Borecki I, Chagnon YC, Gagnon J, et al. 2000a. The Na(+)-K(+)-ATPase alpha.2 gene and trainability of cardiorespiratory endurance: the HERITAGE family study. J. Appl. Physiol. 88:346-51
73. Rankinen T, Perusse L, Gagnon J, Chagnon YC, Leon AS, et al. 2000b. Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study. J. Appl. Physiol. 88:1029-35
74. Riechman SE, Balasekaran G, Roth SM, Ferrell RE. 2004. Association of interleukin-15 protein and interleukin- 15 receptor genetic variation with resistance exercise training responses. J. Appl. Physiol. 97:2214-19
75. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1343-46
76. 2max in the HERITAGE Family Study. Med. Sci. Sports Exerc. 29:1311-17
77. Roltsch MH, Brown MD, Hand BD, Kostek MC, Phares DA, et al. 2005. No association between ACE I/D polymorphism and cardiovascular hemodynamics during exercise in young women. Int. J. Sports Med. 26:638-44
78. Roth SM, Metter EJ, Lee MR, Hurley BF, Ferrell RE. 2003. C174T polymorphism in the CNTF receptor gene is associated with fat-free mass in men and women. J. Appl. Physiol. 95:1425-30
79. Roth SM, Schrager MA, Ferrell RE, Riechman SE, Metter EJ, et al. 2001. CNTF genotype is associated with muscular strength and quality in humans across the adult age span. J. Appl. Physiol. 90:1205-10
80. Sainz J, Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V. 1997. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N. Engl. J. Med. 337:77-82
81. Sayer AA, Syddall H, O'Dell SD, Chen XH, Briggs PJ, et al. 2002. Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age Ageing 31:468-70
82. Schrager MA, Roth SM, Ferrell RE, Metter EJ, Russek-Cohen E, et al. 2004. Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span. J. Appl. Physiol. 97:2176-83
83. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. 1990. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J. Clin. Invest. 86:1913-20
84. Scott RA, Moran C, Wilson RH, Onywera V, Boit MK et al. 2005. No association between Angiotensin Converting Enzyme (ACE) gene variation and endurance athlete status in Kenyans. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 141:169-75
85. Seeman E, Hopper JL, Young NR, Formica C, Goss P, Tsalamandris C. 1996. Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study. Am. J. Physiol. 270:E320-27
86. Swan L, Birnie DH, Padmanabhan S, Inglis G, Connell JM, Hillis WS. 2003. The genetic determination of left ventricular mass in healthy adults. Eur Heart J. 24:577-82
87. Taguchi T, Kishikawa H, Motoshima H, Sakai K, Nishiyama T, et al. 2000. Involvement of bradykinin in acute exercise-induced increase of glucose uptake and GLUT-4 translocation in skeletal muscle: studies in normal and diabetic humans and rats. Metabolism 49:920-30
88. Tanriverdi H, Evrengul H, Tanriverdi S, Turgut S, Akdag B, et al. 2005. Improved endothelium dependent vasodilation in endurance athletes and its relation with ACE I/D polymorphism. Circ. J. 69:1105-10
89. Thomis MA, Beunen GP, Maes HH, Blimkie CJ, Van Leemputte M, et al. 1998a. Strength training: importance of genetic factors. Med. Sci. Sports Exerc. 30:724-31
90. Thomis MA, Beunen GP, Van Leemputte M, Maes HH, Blimnkie CJ, et al. 1998b. Inheritance of static and dynamic arm strength and some of its determinants. Acta Physiol. Scand. 163:59-71
91. Tiainen K, Sipila S, Alen M, Heikkinen E, Kaprio J, et al. 2004. Heritability of maximal isometric muscle strength in older female twins. J. Appl. Physiol. 96:173-80
92. Tiainen K, Sipila S, Alen M, Heikkinen E, Kaprio J, et al. 2005. Shared genetic and environmental. effects on strength and power in older female twins. Med. Sci. Sports Exerc. 37:72-78
93. Tsianos G, Eleftheriou KI, Hawe E, Woolrich L, Watt M, et al. 2005. Performance at altitude and angiotensin I-converting enzyme genotype. Eur J. Appl. Physiol. 93:630-33
94. Tsianos G, Sanders J, Dhamrait S, Humphries S, Grant S, Montgomery H. 2004. The ACE gene insertion/deletion polymorphism and elite endurance swimming. Eur. J. Appl. Physiol. 92:360-62
95. Van Pottelbergh I, Goemacre S, Nuytinck L, De Paepe A, Kaufman JM. 2001. Association of the type I collagen alphal Sp1 polymorphism, bone density and upper limb muscle strength in community-dwelling elderly men. Osteoporos Int. 12:895-901
96. van Rossum EF, Voorhoeve PG, te Velde SJ, Koper JW, Delemarre-van de Waal HA, et al. 2004. The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial bodycomposition and muscle strength in young adults. J. Clin. Endocrinol. Metab. 89:4004-9
97. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, et al. 2002. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J. Gerontol. A Biol. Sci. Med. Sci. 57.M326-32
98. Welsby IJ, Podgoreanu MV, Phillips-Bute B, Mathew JP, Smith PK, et al. 2005. Genetic factors contribute to bleeding after cardiac surgery. J. Thromb. Haemost. 3:1206-12
99. Wicklmayr M, Dietze G. 1979. Improvement of insulin action by bradykinin in the alloxan-diabetic rat. FEBS Lett. 106:125-28
100. Wicklmayr M, Dietze G, Gunther B, Schifmann R, Bottger I, et al. 1980. The kallikrein-kinnin system and muscle metabolism-clinical aspects. Agents Actions 10:339-43
101. Williams AG, Dhamrait SS, Wootton PT, Day SH, Hawe E, et al. 2004. Bradykinin receptor gene variant and human physical performance. J. Appl. Physiol. 96:938-42
102. Williams AG, Rayson MP, Jubb M, World M, Woods DR, et al. 2000. The ACE gene and muscle performance. Nature 403:614
103. Woods D, Hickman M, Jamshidi Y, Brull D, Vassiliou V, et al. 2001a. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum. Genet. 108:230-32
104. Woods D, Onambele G, Woledge R, Skelton D, Bruce S, et al. 2001b. Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density. J. Clin. Endocrinol. Metab. 86:2200-4
105. Woods DR, Brull D, Montgomery BE. 2000. Endurance and the ACE I/D polymorphism. Sci. Prog. 83:317-36
106. Woods DR, Pollard AJ, Collier DJ, Jamshidi Y, Vassiliou V, et al. 2002a. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude. Am. J. Respir. Crit. Care Med. 166:362-66
107. Woods DR, World M, Rayson MP, Williams AG, Jubb M, et al. 2002b. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training. Eur. J. Appl. Physiol. 86:240-24
108. Wufuer M, Fang MW, Cheng ZH, Qiu CC. 2004. Polymorphism of angiotensin converting enzyme gene and natural longevity in the Xinjiang Uygur people: an association study. Zhonghua Yi Xue Za Zhi 84:1603-6
109. Yang N, MacArthur DG. 2003. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet. 73:627-31
110. Young LE, Rogers K, Wood JL. 2005. Left ventricular size and systolic function in Thorough-bred racehorses and their relationships to race performance. J. Appl. Physiol. 99:1278-85
111. Zhang B, Tanaka H, Shono, N, Miura S, Kiyonaga A, et al. 2003. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin. Genet. 63:139-44